Cargando…
Sodium-glucose cotransporter 2 inhibitors and mitochondrial functions: state of the art
Sodium-glucose cotransporter 2 inhibitors (SGLT2is) are a class of newly introduced antidiabetic drugs with potent hypoglycemic effects. Recent evidence suggests that these drugs have extraglycemic impacts and are therefore able to provide additional benefits beyond glucose lowering. Mitochondrial d...
Autores principales: | Yaribeygi, Habib, Maleki, Mina, Butler, Alexandra E., Jamialahmadi, Tannaz, Sahebkar, Amirhossein |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Leibniz Research Centre for Working Environment and Human Factors
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939776/ https://www.ncbi.nlm.nih.gov/pubmed/36814854 http://dx.doi.org/10.17179/excli2022-5482 |
Ejemplares similares
-
Hepatic benefits of sodium-glucose cotransporter 2 inhibitors in liver disorders
por: Yaribeygi, Habib, et al.
Publicado: (2023) -
Sodium Glucose Cotransporter-2 Inhibitor Empagliflozin Increases Antioxidative Capacity and Improves Renal Function in Diabetic Rats
por: Yaribeygi, Habib, et al.
Publicado: (2023) -
Molecular Mechanisms by Which Imeglimin Improves Glucose Homeostasis
por: Yaribeygi, Habib, et al.
Publicado: (2020) -
The Impact of Incretin-Based Medications on Lipid Metabolism
por: Yaribeygi, Habib, et al.
Publicado: (2021) -
Molecular mechanisms linking stress and insulin resistance
por: Yaribeygi, Habib, et al.
Publicado: (2022)